Treating chronic lymphocytic leukemia with a combination of rituximab and alemtuzumab: a “successful couple,” but are they still relevant together?

Christian H Geisler; Tamar Tadmor; Aaron Polliack

doi:10.3109/10428194.2014.946026

Treating chronic lymphocytic leukemia with a combination of rituximab and alemtuzumab: a “successful couple,” but are they still relevant together?

Christian H Geisler, Tamar Tadmor, Aaron Polliack

IKM

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning

Originalsprog	Engelsk
Tidsskrift	Leukemia and Lymphoma
Vol/bind	56
Udgave nummer	2
Sider (fra-til)	275-276
Antal sider	2
ISSN	1042-8194
DOI	https://doi.org/10.3109/10428194.2014.946026
Status	Udgivet - feb. 2015

Adgang til dokumentet

10.3109/10428194.2014.946026

Citationsformater

@article{008f7d9096184eaa83c7fef7dac26050,

title = "Treating chronic lymphocytic leukemia with a combination of rituximab and alemtuzumab: a “successful couple,” but are they still relevant together?",

author = "Geisler, {Christian H} and Tamar Tadmor and Aaron Polliack",

year = "2015",

month = feb,

doi = "10.3109/10428194.2014.946026",

language = "English",

volume = "56",

pages = "275--276",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor & Francis",

number = "2",

}

TY - JOUR

T1 - Treating chronic lymphocytic leukemia with a combination of rituximab and alemtuzumab

T2 - a “successful couple,” but are they still relevant together?

AU - Geisler, Christian H

AU - Tadmor, Tamar

AU - Polliack, Aaron

PY - 2015/2

Y1 - 2015/2

U2 - 10.3109/10428194.2014.946026

DO - 10.3109/10428194.2014.946026

M3 - Comment/debate

C2 - 25065699

SN - 1042-8194

VL - 56

SP - 275

EP - 276

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 2

ER -